NASDAQ Companies

NEW YORK, Feb. 28, 2024 (GLOBE NEWSWIRE) — Royalty Pharma plc (Nasdaq: RPRX) today announced that it will participate in […]

THORNTON, Colo., Feb. 28, 2024 (GLOBE NEWSWIRE) — MYR Group Inc. (“MYR”) (NASDAQ: MYRG), a holding company of leading specialty […]

— Record Fourth Quarter Net Sales Rise 14.4 Percent to $1.73 Billion —— Net Sales, Adjusted for Adverse Changes in […]

WESTLAKE VILLAGE, Calif., Feb. 28, 2024 (GLOBE NEWSWIRE) — Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing […]

RAMSEY, N.J. and BOCA RATON, Fla., Feb. 28, 2024 (GLOBE NEWSWIRE) — ADMA Biologics, Inc. (Nasdaq: ADMA) (“ADMA” or the […]

– Quarterly Revenue of $130.4 million, up 38% Year-Over-Year – – Gross Margin of 42.5% – – Net Income of $16.6 million – – Adjusted […]

RESTON, Va,, Feb. 28, 2024 (GLOBE NEWSWIRE) — Lightbridge Corporation (“Lightbridge”) (Nasdaq: LTBR), an advanced nuclear fuel technology company, announced […]

SEATTLE, Feb. 28, 2024 (GLOBE NEWSWIRE) — Trupanion, Inc. (Nasdaq: TRUP) announced today that Margi Tooth, President, will present at the […]

Q4 2023 Net Sales, Net Income, Adjusted EBITDA and EPS Increase to Record Levels FY 2023 Net Sales Increased 16% to […]

Anticipate 2024 Product Revenue Growth of at Least 10% vs. 2023 Excluding Enzyme Sales Related to PAXLOVID™ Recently Announced Debt […]